ArticleEpileptic disorders : international epilepsy journal with videotape2025
Radiofrequency thermocoagulation for the treatment of refractory focal status epilepticus.
Article in Epileptic disorders : international epilepsy journal with videotape, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Right amygdala ablation reduces maladaptive negative interpretation bias and symptoms in a patient with post-traumatic stress disorder.Nature communications · 2026Article
- Radiofrequency thermocoagulation for the treatment of refractory focal status epilepticus.Epileptic disorders : international epilepsy journal with videotape · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case study reports the first documented use of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC) to treat refractory status epilepticus (RSE). A 33-year-old woman with drug-resistant epilepsy and recurrent RSE underwent SEEG to define her epileptogenic zone. A new RSE started shortly before and continued during the SEEG exploration, being unresponsive to multiple antiseizure medications, vagal nerve stimulation, and corticosteroid therapy. SEEG-signal quantification based on ictal biomarkers, that is, epileptogenicity index and connectivity epileptogenicity index, identified the epileptogenic zone network (EZN) within the mesial prefrontal, premotor, and parietal cortex, with major implication of the anterior-middle and posterior cingulate cortex. RFTC was performed on SEEG-identified targets within the EZN and resulted in rapid cessation of electroclinical seizure activity and full recovery from motor deficits. Seizure frequency remained reduced by over 90% at 4 months post-procedure. This case highlights the potential of RFTC as a possible therapeutic option for RSE by directly disrupting critical network nodes responsible for seizure generation and propagation. The findings also suggest a broader role of SEEG not only for diagnostic purposes but also for the therapeutic management of refractory seizures, including status epilepticus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.